Nov 18, 2019: Dr Catherine Hogan at Cardiff University’s European Cancer Stem Cell Research Institute has been awarded the funding of £373k by Cancer Research UK’s Early Detection Committee to understand new ways to diagnose pancreatic cancer at an earlier stage.
Her research showed that cells with the mutated KRAS gene (holds 90% of pancreatic cancer) are often eliminated due to protective mechanisms that keep the tissue healthy.
Nowadays many people survive with cancer and this doubled in the last 40 years in UK so funding awarded will helps a lot in investigating whether having more mutations in KRAS mutated cells enables them to avoid the protective mechanisms in the pancreas and initiate cancer development. https://www.cancerresearchuk.org/about-us/cancer-news/press-release/2019-11-06-cardiff-scientist-awarded-ps373k-to-find-new-ways-to-diagnose-pancreatic-cancer-earlier?_ga=2.170261608.979509868.1574138627-821077033.1573061409
